| Lactose (India) Ltd | 159 Cr. | 127 | 247/84.3 | 35.3 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.52 Cr. | 1.84 | 4.33/1.82 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,497 Cr. | 413 | 479/192 | 93.1 | 24.3 | 0.16 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.6 Cr. | 44.0 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 39.5 Cr. | 27.0 | 29.1/17.0 | 94.1 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 58.2 Cr. | 77.3 | 134/77.0 | 15.7 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 51,944 Cr. | 1,844 | 2,286/1,275 | 20.7 | 340 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 334 Cr. | 13.7 | 19.9/10.8 | 20.0 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 19.2/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 880 Cr. | 1,863 | 1,971/635 | 30.4 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 102 Cr. | 20.4 | 32.0/16.6 | 27.9 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 820 Cr. | 279 | 449/219 | 7.32 | 133 | 0.90 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 8.86 Cr. | 3.56 | 9.28/2.11 | 5.04 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 423 Cr. | 435 | 477/135 | 63.8 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,625 Cr. | 1,062 | 1,565/1,038 | 41.8 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 57.2 Cr. | 0.28 | 1.24/0.26 | 3.77 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 40.6 Cr. | 16.9 | 26.3/6.60 | 41.9 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 10.3 Cr. | 10.2 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 178 Cr. | 498 | 859/443 | 10.1 | 596 | 0.30 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 78.9 Cr. | 78.9 | 92.5/26.1 | 149 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,950 Cr. | 1,428 | 2,452/1,345 | 46.5 | 174 | 0.75 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 19.3 Cr. | 42.1 | 88.7/36.1 | 41.9 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 15.5 Cr. | 6.19 | 7.66/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 17.7 Cr. | 118 | 154/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 49.2 Cr. | 89.9 | 89.9/9.41 | 33.9 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.1 Cr. | 40.0 | 80.0/37.1 | 48.6 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.24 Cr. | 20.8 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,629 Cr. | 555 | 1,028/492 | 27.3 | 72.4 | 0.22 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 87.3 Cr. | 20.2 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.5 Cr. | 22.8 | 43.7/17.4 | 50.2 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 92,646 Cr. | 2,242 | 3,055/2,115 | 55.6 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 225 Cr. | 390 | 524/241 | 23.0 | 123 | 1.15 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 54.1 Cr. | 37.7 | 62.6/26.7 | 84.6 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 70,620 Cr. | 1,206 | 1,365/994 | 20.6 | 603 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 159 Cr. | 256 | 303/159 | 152 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 796 Cr. | 79.6 | 123/74.0 | 20.6 | 32.6 | 1.89 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 35.0 Cr. | 26.8 | 50.0/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,928 Cr. | 1,702 | 1,868/919 | 62.2 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.09 Cr. | 0.62 | 1.45/0.55 | 102 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 232 Cr. | 30.3 | 68.0/29.1 | 14.9 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 5.65 Cr. | 9.66 | 23.8/9.40 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 137 Cr. | 5.82 | 6.57/2.82 | 319 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 62,925 Cr. | 29,575 | 37,000/25,260 | 41.7 | 1,888 | 1.61 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,291 Cr. | 694 | 972/550 | 26.2 | 226 | 0.72 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 268 Cr. | 92.7 | 100/31.3 | 75.0 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 5,111 Cr. | 1,685 | 1,740/556 | | 104 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,311 Cr. | 1,311 | 1,870/1,110 | 388 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 799 Cr. | 230 | 330/154 | 18.6 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 935 Cr. | 701 | 725/270 | 14.8 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,274 Cr. | 466 | 900/438 | 22.5 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,592 Cr. | 1,128 | 1,595/991 | 22.6 | 768 | 0.89 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,24,885 Cr. | 3,686 | 3,882/2,886 | 57.6 | 250 | 0.87 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,002 Cr. | 109 | 310/98.0 | | 41.3 | 0.46 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,493 Cr. | 15.9 | 24.0/14.1 | 23.8 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 22,547 Cr. | 589 | 1,360/574 | 65.6 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,005 Cr. | 176 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,26,902 Cr. | 1,780 | 1,910/1,547 | 37.0 | 324 | 0.90 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,395 Cr. | 548 | 886/441 | 374 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,642 Cr. | 282 | 329/175 | 32.6 | 81.2 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 444 Cr. | 1,438 | 1,680/956 | 23.8 | 683 | 0.10 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,854 Cr. | 351 | 502/265 | 44.3 | 125 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 6,051 Cr. | 239 | 260/111 | 140 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,394 Cr. | 4,513 | 6,718/4,146 | 28.2 | 340 | 2.59 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,725 Cr. | 2,254 | 2,725/1,772 | 33.4 | 335 | 0.89 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,694 Cr. | 5,830 | 6,739/4,904 | 31.6 | 373 | 2.14 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 168 Cr. | 47.6 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,923 Cr. | 5,000 | 5,993/3,701 | 32.4 | 841 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 113 Cr. | 92.2 | 348/81.0 | 11.7 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,110 Cr. | 345 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,398 Cr. | 866 | 1,998/604 | 84.2 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 21,298 Cr. | 16,598 | 19,748/10,060 | 109 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 333 Cr. | 14.8 | 44.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 15,489 Cr. | 865 | 1,505/660 | 10.1 | 483 | 0.69 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,402 Cr. | 44.0 | 91.7/41.7 | 31.8 | 21.8 | 0.45 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,694 Cr. | 192 | 359/162 | 24.7 | 59.3 | 0.42 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 73.5 Cr. | 46.4 | 130/44.5 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 302 Cr. | 84.4 | 177/78.9 | 148 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 92,698 Cr. | 2,029 | 2,403/1,774 | 21.4 | 430 | 0.59 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,064 Cr. | 529 | 980/490 | 13.3 | 357 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 52,800 Cr. | 978 | 1,034/501 | 77.3 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 980 Cr. | 944 | 1,235/596 | 20.0 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 141 Cr. | 65.5 | 129/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 621 Cr. | 129 | 236/128 | 35.3 | 104 | 2.33 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 645 Cr. | 369 | 500/265 | 23.4 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 16,850 Cr. | 1,058 | 1,265/802 | 33.9 | 414 | 0.47 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 27,157 Cr. | 1,730 | 1,952/1,303 | 37.8 | 243 | 0.90 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,347 Cr. | 202 | 328/193 | 30.8 | 38.0 | 1.24 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,667 Cr. | 1,444 | 1,758/1,168 | 37.0 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,656 Cr. | 90.3 | 127/57.5 | 22.9 | 59.7 | 0.89 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 820 Cr. | 101 | 124/67.2 | 27.7 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,378 Cr. | 257 | 355/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,772 Cr. | 225 | 465/220 | 274 | 96.9 | 0.62 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,424 Cr. | 1,672 | 2,768/1,243 | 32.5 | 397 | 0.42 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,539 Cr. | 352 | 498/285 | 65.2 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,212 Cr. | 544 | 628/412 | 25.9 | 164 | 0.28 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 51,944 Cr. | 1,844 | 2,286/1,275 | 20.7 | 340 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 42,320 Cr. | 2,498 | 3,516/1,921 | 44.4 | 101 | 1.68 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 29,824 Cr. | 1,810 | 2,131/1,200 | 25.8 | 610 | 0.99 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,680 Cr. | 411 | 530/359 | 29.6 | 149 | 1.22 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 22,669 Cr. | 1,666 | 1,910/1,097 | 54.5 | 227 | 0.44 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,03,898 Cr. | 1,244 | 1,406/1,020 | 18.0 | 432 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,738 Cr. | 238 | 322/178 | 25.0 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,22,139 Cr. | 1,512 | 1,673/1,310 | 22.4 | 408 | 0.86 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,603 Cr. | 1,919 | 2,641/1,551 | 24.8 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 301 Cr. | 102 | 203/95.6 | 21.5 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,691 Cr. | 160 | 191/105 | 15.4 | 107 | 0.31 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 62.0 Cr. | 38.1 | 72.0/37.7 | 21.8 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 53,044 Cr. | 397 | 425/291 | 112 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,677 Cr. | 1,661 | 2,190/1,430 | 37.0 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 122 Cr. | 76.6 | 134/75.6 | 17.9 | 49.2 | 1.57 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 379 Cr. | 164 | 205/67.8 | 35.8 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,524 Cr. | 8,988 | 10,691/6,301 | 97.4 | 320 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,014 Cr. | 696 | 843/544 | 35.5 | 118 | 0.66 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 164 Cr. | 78.6 | 137/78.0 | 8.73 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 68,124 Cr. | 5,700 | 5,868/4,492 | 29.0 | 1,116 | 0.79 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 17,724 Cr. | 901 | 1,124/725 | 27.9 | 271 | 1.22 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 444 Cr. | 787 | 1,540/763 | | 690 | 0.64 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 31,028 Cr. | 2,486 | 3,116/2,022 | 31.9 | 345 | 1.13 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,556 Cr. | 317 | 412/258 | 24.1 | 133 | 1.64 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,063 Cr. | 442 | 575/312 | 21.3 | 146 | 0.23 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,140.56 Cr | 1,177.13 | | 52.88 | 202.40 | 0.35% | 16.24% | 14.95% | 6.10 |